2 active not recruiting, 2 completed, 2 recruiting. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Active not recruiting 2, Completed 2, Recruiting 2 |
Follow Fluciclovine F18: new trials by email Literature Review of Fluciclovine F18 trials Research Report on Fluciclovine F18
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) Biopsy Procedure, Biospecimen Collection, Chest Radiography - Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 50 | 2024-06-25 | 2026-10-14 |
| Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Fluciclovine F18, Gadolinium-Chelate - Glioblastoma, IDH-Wildtype | Phase 2 | Recruiting | ECOG-ACRIN Cancer Research Group | 100 | 2024-04-11 | 2026-08-18 |
| Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study Biospecimen Collection, Bone Scan, Computed Tomography - Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Active not recruiting | NRG Oncology | 194 | 2022-04-20 | 2026-08-17 |
| Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes Computed Tomography, Fluciclovine F18, Gallium Ga68-labeled PSMA-11 - Prostate Adenocarcinoma | Phase 2 | Active not recruiting | Emory University | 140 | 2019-05-10 | 2026-09-02 |
| Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery Computed Tomography, Fluciclovine F18, Gallium Ga 68-labeled PSMA-11 - Recurrent Prostate Carcinoma | Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 50 | 2019-04-12 | 2020-10-14 |
| Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone | Phase 2 | Completed | University of Utah | 17 | 2018-10-02 | 2024-11-29 |
Prostatic Neoplasms (3) · Glioblastoma (1) · Nasopharyngeal Carcinoma (1)
ECOG-ACRIN Cancer Research Group (1) · Emory University (1) · Jonsson Comprehensive Cancer Center (1) · NRG Oncology (1) · National Cancer Institute (NCI) (1) · University of Utah (1)
United States (6) · Canada (2) · Australia (1) · New Zealand (1) · Puerto Rico (1)
Ashesh Jani, MD, MSEE (1) · Bridget F Koontz (1) · Daniel P Barboriak (1) · Jeffrey Yap, PhD (1) · Johannes Czernin, M.D. (1) · Robyn D Gartrell (1)
P30CA138292 (1), R01CA226992 (1), U10CA180820 (1), U10CA180868 (1), U10CA180886 (1)